BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 18667797)

  • 1. Sympathetic nervous system-immune interactions in autoimmune lymphoproliferative diseases.
    del Rey A; Besedovsky HO
    Neuroimmunomodulation; 2008; 15(1):29-36. PubMed ID: 18667797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disease and innervation.
    Straub RH
    Brain Behav Immun; 2007 Jul; 21(5):528-34. PubMed ID: 17517488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice.
    del Rey A; Roggero E; Kabiersch A; Schäfer M; Besedovsky HO
    J Immunol; 2006 Jun; 176(11):7079-86. PubMed ID: 16709870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sympathetic nervous system modulates CD4(+)Foxp3(+) regulatory T cells via noradrenaline-dependent apoptosis in a murine model of lymphoproliferative disease.
    Wirth T; Westendorf AM; Bloemker D; Wildmann J; Engler H; Mollerus S; Wadwa M; Schäfer MK; Schedlowski M; del Rey A
    Brain Behav Immun; 2014 May; 38():100-10. PubMed ID: 24440144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the sympathetic nervous system in the thymus in health and disease.
    Roggero E; Besedovsky HO; del Rey A
    Neuroimmunomodulation; 2011; 18(5):339-49. PubMed ID: 21952686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the immune system by the autonomic nervous system and its implication in immunological changes after training.
    Nagatomi R; Kaifu T; Okutsu M; Zhang X; Kanemi O; Ohmori H
    Exerc Immunol Rev; 2000; 6():54-74. PubMed ID: 10919062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic abnormalities during autoimmune processes: potential relevance of noradrenaline-induced apoptosis.
    Del Rey A; Kabiersch A; Petzoldt S; Besedovsky HO
    Ann N Y Acad Sci; 2003 May; 992():158-67. PubMed ID: 12794055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It takes nerve to tell T and B cells what to do.
    Kin NW; Sanders VM
    J Leukoc Biol; 2006 Jun; 79(6):1093-104. PubMed ID: 16531560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic-mediated immunomodulation and potential clinical relevance.
    Benarroch EE
    Neurology; 2009 Jul; 73(3):236-42. PubMed ID: 19620613
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
    Lim WK; Ursea R; Rao K; Buggage RR; Suhler EB; Dugan F; Chan CC; Straus SE; Nussenblatt RB
    Am J Ophthalmol; 2005 Mar; 139(3):562-3. PubMed ID: 15767081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic dysfunction in autoimmune rheumatic disease.
    Stojanovich L
    Autoimmun Rev; 2009 Jun; 8(7):569-72. PubMed ID: 19393212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine influences and sympathetic neural modulation of immune responsiveness.
    Madden KS; Sanders VM; Felten DL
    Annu Rev Pharmacol Toxicol; 1995; 35():417-48. PubMed ID: 7598501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsynaptic noradrenaline release in neuro-immune responses.
    Vizi ES; Elenkov IJ
    Acta Biol Hung; 2002; 53(1-2):229-44. PubMed ID: 12064774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity.
    Szyper-Kravitz M; Zandman-Goddard G; Lahita RG; Shoenfeld Y
    Rheum Dis Clin North Am; 2005 Feb; 31(1):161-75, x. PubMed ID: 15639061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimmunomodulatory interactions in the genesis and outcome of autoimmune disease.
    Savino W
    Neuroimmunomodulation; 2008; 15(1):5-6. PubMed ID: 18667794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
    Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
    Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychoneuroimmunology of autoimmune disorders.
    Rogers MP; Fozdar M
    Adv Neuroimmunol; 1996; 6(2):169-77. PubMed ID: 8876772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-immune interactions and disease susceptibility.
    Marques-Deak A; Cizza G; Sternberg E
    Mol Psychiatry; 2005 Mar; 10(3):239-50. PubMed ID: 15685252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.